Biogen Idec to launch buyback of $3b in stock
97416
THE REGION Cambridge Drug maker Biogen Idec Inc. said it would start buying $3 billion worth of its own shares, potentially cutting the number of outstanding shares by one-sixth. Chief executive James Mullen said strong cash flows from sales of Avonex, for multiple sclerosis, and Rituxan, for non-Hodgkin's lymphoma, allowed the company to return money to shareholders in a tender ...
539940
The Web search company said it will commence its share  buyback offer today for the 23.4 million common shares it may  have issued improperly to previous and current employees and  consultants.
9084
SAN RAMON, Calif. -- Chevron Corp., the second-largest U.S. oil company, said Wednesday its board approved a three-year, $15 billion share buyback program.
68983
The board of IBM Corp. has authorized up to $4 billion in additional funding for its stock buyback program. Armonk, NY-based IBM (NYSE: IBM) says it will repurchase shares on the open market or in private
427900
BOSTON  Â Biogen Idec said on Wednesday its fourth-quarter profit rose 84 percent, topping expectations, driven by increased sales of its multiple sclerosis drugs Avonex and Tysabri.
249246
Genentech and Biogen Idec's drug shows positive results against multiple sclerosis.
423442
Gilead Sciences Inc. , the world's third-biggest biotechnology company, said on Monday it has agreed to acquire Myogen Inc.  for $2.5 billion in a surprise transaction that gives Gilead access to Myogen's experimental hypertension drugs.
541178
General Electric Co., the world&#39;s biggest company by market value, will buy back as much as $15 billion in stock and raise its dividend as Chief Executive Jeffrey Immelt&#39;s growth strategy generates more cash and profit.
100503
The electronics retailer said it would immediately start a $5.5 billion buyback program and raise its quarterly dividend nearly a third.
234249
Moving to strengthen its offerings to treat cancer, Biogen Idec Inc. of Cambridge yesterday signed a deal to license tumor-killing technology from ImmunoGen Inc.
267375
Investors in the biotechnology company Biogen Idec announced Wednesday that it had not received any definitive offers after putting itself up for sale two months ago.
142092
SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in after-hours trading Tuesday after Tysabri, a drug used for the treatment of multiple sclerosis, was approved by the US Food and Drug Administration.
690464
Carl Icahn, the billionaire investor who recently helped put Biogen Idec Inc. in play, has taken a stake in another major Cambridge biotech - Genzyme Corp.
260459
Diversified manufacturer 3M Co.  on Wednesday said it has agreed to buy for Biotrace International PLC , a U.K.-based maker of industrial microbiology products, for about $98 million.
550590
Danish biotechnology company Genmab broke through the gloom in European markets to jump 5 per cent to DKr338 on rumours of a bid by US-based Biogen Idec.
84876
Shares of ID Biomedical jumped after the company reported Monday that it signed long-term agreements with the three largest flu vaccine wholesalers in the United States in light of the shortage of vaccine for the current flu season.
59608
Standard &amp; Poor&#39;s Equity Research reiterated a &quot;hold&quot; rating and $68 target price on Biogen Idec (nasdaq: BIIB - news - people ), saying the anticipated success of the company&#39;s Antegren drug is largely factored into the share price.